Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
The 3 Best Biotech Stocks to Buy in January 2024
11:01pm, Tuesday, 09'th Jan 2024
Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks. Look at obesity drug stocks, like Eli Lilly (NYSE: LLY )
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
08:09am, Tuesday, 02'nd Jan 2024
Two factors –lower interest rates and the low valuation of many biotech stocks — are likely to result in many biotech companies being acquired in 2024. Lower interest rates will result in many dru
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?
11:17am, Wednesday, 20'th Dec 2023
The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say.
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
08:45am, Tuesday, 12'th Dec 2023
Small to mid-cap biotechs are known for their extreme volatility, and sometimes, market-crushing returns on capital. Iovance Biotherapeutics and Viking Therapeutics are two of the most popular stocks
Why Viking Therapeutics Was Crushing It This Week
08:14am, Friday, 08'th Dec 2023
Viking Therapeutics benefitted indirectly from a big-ticket buyout of a peer. Roche could end up paying over $3 billion in that deal.
1 Under-the-Radar Stock That Could Triple By 2030
07:30am, Saturday, 04'th Nov 2023
Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two leading candidates are currently in phase 2 clinical trials.
Why Is Viking Therapeutics (VKTX) Stock Moving Today?
10:01am, Wednesday, 18'th Oct 2023
Viking Therapeutics (NASDAQ: VKTX ) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial. This data comes from its Phase 1 study of VK2735
Viking Therapeutics joins weight loss drug bandwagon as trial data impresses
07:06am, Wednesday, 18'th Oct 2023
Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a treatment utilising GLP-1 receptors. Data from the phase 1
Viking Therapeutics' stock rallies following early drug study data
04:56pm, Tuesday, 17'th Oct 2023
Viking Therapeutics Inc. VKTX, -0.37% shares rose in the extended session Tuesday after the biotech drug developer said data from an early stage clinical study showed its drug candidate reduced liver
Viking Therapeutics to Participate at Upcoming Investor Conferences
04:05pm, Thursday, 07'th Sep 2023
SAN DIEGO , Sept. 7, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic an
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
07:07pm, Wednesday, 16'th Aug 2023
Investors always hope to buy low and sell high. In order to do so, it's necessary to identify stocks that are undervalued.
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
02:16pm, Wednesday, 09'th Aug 2023
The stock of biotech Viking Therapeutics Inc. was up 4% Wednesday to extend its week-to-date gains to 13%, after positive news on Novo Nordisk's obesity drugs reducing the risk of cardio events ignite
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today
11:45am, Tuesday, 08'th Aug 2023
Novo Nordisk's popular weight loss drug significantly reduced the risk of heart attack or stroke in a late-stage trial. These data bode well for the obesity drug category at large.
2 Magnificient Growth Stocks I'm Buying in August
11:15am, Wednesday, 02'nd Aug 2023
Growth stocks have returned to form this year. Roivant Sciences and Viking Therapeutics are two growth plays that should interest risk-tolerant investors.
3 Top Biotech Stocks Defying the Bear Market
07:45am, Thursday, 13'th Jul 2023
Vertex Pharmaceuticals' strong pipeline is positioning the company for the future. Viking Therapeutics' stock is soaring as the market anticipates its candidate drugs hitting the marketplace.
